We are live on
!
Find out more
SEC
Seven Eight Capital Portfolio holdings
AUM
$1.11B
1-Year Est. Return
29.48%
This Fund
S&P 500
This Quarter
Est. Return
-0.09%
1 Year Est. Return
+29.48%
3 Year Est. Return
+13.61%
5 Year Est. Return
+117.69%
10 Year Est. Return
+239.1%
AUM
$235M
AUM Growth
+$87.8M
(+60%)
Cap. Flow
+$81.1M
Cap. Flow
% of AUM
34.53%
Top 10 Holdings %
Top 10 Hldgs %
9.76%
Holding
779
New
236
Increased
178
Reduced
104
Closed
257
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$2.52M |
| 2 |
Keurig Dr Pepper
KDP
|
+$2.4M |
| 3 |
Wells Fargo
WFC
|
+$2.19M |
| 4 |
AET
Aetna Inc
AET
|
+$2.17M |
| 5 |
PNC Financial Services
PNC
|
+$2.15M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Halliburton
HAL
|
+$1.39M |
| 2 |
Eaton
ETN
|
+$1.38M |
| 3 |
CB
CHUBB CORPORATION
CB
|
+$1.35M |
| 4 |
XEC
CIMAREX ENERGY CO
XEC
|
+$1.32M |
| 5 |
DaVita
DVA
|
+$1.26M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.9% |
| 2 | Consumer Discretionary | 14.51% |
| 3 | Industrials | 13.73% |
| 4 | Financials | 13.03% |
| 5 | Healthcare | 10.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Mondelez International
MDLZ
$80.1B
| $1.67M | 0.71% |
+41,710
| New | +$1.7M |
|
|
CAM
27
DELISTED
CAMERON INTERNATIONAL CORPORATION
CAM
| $1.64M | 0.7% |
24,400
+23,000
| +1,643% | +$1.48M |
|
28
Occidental Petroleum
OXY
$53.9B
| $1.61M | 0.69% |
+23,549
| New | +$1.58M |
|
|
EMC
29
DELISTED
EMC CORPORATION
EMC
| $1.6M | 0.68% |
59,875
+51,500
| +615% | +$1.3M |
|
|
BNY
30
Bank of New York Mellon
BNY
$106B
| $1.58M | 0.67% |
42,937
+10,200
| +31% | +$370K |
|
31
Tesla
TSLA
$1.21T
| $1.51M | 0.64% |
+98,520
| New | +$1.3M |
|
32
Darden Restaurants
DRI
$23.8B
| $1.5M | 0.64% |
22,618
+19,800
| +703% | +$1.25M |
|
33
Huntington Bancshares
HBAN
$34.6B
| $1.46M | 0.62% |
153,300
+149,000
| +3,465% | +$1.37M |
|
|
TYC
34
DELISTED
TYCO INTL PLC COM SHS (IRL)
TYC
| $1.46M | 0.62% |
+37,994
| New | +$1.36M |
|
35
American Airlines Group
AAL
$10.1B
| $1.45M | 0.62% |
35,462
+33,900
| +2,170% | +$1.36M |
|
36
Applied Materials
AMAT
$377B
| $1.44M | 0.61% |
+67,936
| New | +$1.24M |
|
37
PepsiCo
PEP
$194B
| $1.44M | 0.61% |
14,000
+13,100
| +1,456% | +$1.29M |
|
|
RTN
38
DELISTED
Raytheon Company
RTN
| $1.43M | 0.61% |
11,666
+10,400
| +821% | +$1.28M |
|
39
TechnipFMC
FTI
$28.9B
| $1.42M | 0.6% |
69,567
+46,637
| +203% | +$880K |
|
40
KLA
KLAC
$250B
| $1.41M | 0.6% |
194,000
+184,000
| +1,840% | +$1.24M |
|
41
Starbucks
SBUX
$117B
| $1.4M | 0.6% |
23,456
+20,900
| +818% | +$1.22M |
|
|
MON
42
DELISTED
Monsanto Co
MON
| $1.38M | 0.59% |
+15,681
| New | +$1.42M |
|
43
MSCI
MSCI
$42.1B
| $1.37M | 0.58% |
18,499
+17,400
| +1,583% | +$1.2M |
|
44
Signet Jewelers
SIG
$3.77B
| $1.36M | 0.58% |
+10,950
| New | +$1.25M |
|
45
Aon
AON
$81.2B
| $1.31M | 0.56% |
12,500
+8,100
| +184% | +$759K |
|
46
Union Pacific
UNP
$177B
| $1.3M | 0.56% |
+16,411
| New | +$1.27M |
|
|
ESRX
47
DELISTED
Express Scripts Holding Company
ESRX
| $1.3M | 0.55% |
18,970
+5,700
| +43% | +$410K |
|
48
Oracle
ORCL
$347B
| $1.28M | 0.54% |
31,281
+18,400
| +143% | +$681K |
|
|
YOKU
49
DELISTED
YOUKU TUDOU INC.(CAYMAN ISLS)
YOKU
| $1.27M | 0.54% |
+46,300
| New | +$1.26M |
|
50
ConocoPhillips
COP
$139B
| $1.27M | 0.54% |
31,502
+28,361
| +903% | +$1.08M |
|
Similar funds
PP
ECM
GCAC
CAM
D
GFS
FTIS
AIA
Seven Eight Capital's Q1 2016 Portfolio in Review
As of Q1 2016, Seven Eight Capital held 779 positions worth $235M, up 60% from $147M the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.
Seven Eight Capital deployed $81.1M of net new capital in Q1 2016, opening 236 new positions and adding to 178 existing holdings. Its largest new stake was Allergan plc: 8,800 shares worth $2.36M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 12% a quarter earlier, followed by Consumer Discretionary and Industrials.
On the sell side, the largest reduction was Gilead Sciences, an estimated $884K trimmed.
- Seven Eight Capital's largest Q1 2016 buy was Allergan plc: 8,800 shares worth $2.36M.
- Seven Eight Capital added most to Wells Fargo in Q1 2016, an estimated $2.19M increase.
- Seven Eight Capital's biggest Q1 2016 reduction was Gilead Sciences, cutting an estimated $884K.
- Seven Eight Capital fully exited Halliburton in Q1 2016, selling an estimated $1.39M.
- Seven Eight Capital's ten largest holdings make up 9.8% of its $235M portfolio in Q1 2016.
- Seven Eight Capital opened 236 new positions and closed 257 in Q1 2016.
- Seven Eight Capital's portfolio value rose 60% quarter-over-quarter to $235M.
Based on Seven Eight Capital's 13F filing for Q1 2016, filed 16 May 2016.